BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asherson RA, Cervera R. Antiphospholipid antibodies and infections. Ann Rheum Dis. 2003;62:388-393. [PMID: 12695147 DOI: 10.1136/ard.62.5.388] [Cited by in Crossref: 148] [Cited by in F6Publishing: 121] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Tzang BS, Lee YJ, Yang TP, Tsay GJ, Shi JY, Tsai CC, Hsu TC. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein. Clin Chim Acta 2007;382:31-6. [PMID: 17451664 DOI: 10.1016/j.cca.2007.03.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
2 Blank M, Shoenfeld Y. Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. Clin Immunol 2004;112:190-9. [PMID: 15240163 DOI: 10.1016/j.clim.2004.02.018] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
3 Chatzidaki V, Richards M, Darling JC. Thirteen-year-old female with an unusual presentation of deep venous thrombosis. J Paediatr Child Health 2012;48:361-3. [PMID: 22112022 DOI: 10.1111/j.1440-1754.2011.02252.x] [Reference Citation Analysis]
4 Hoxha A, Calligaro A, Bortolati M, Tonello M, Guariso G, Ruffatti A. The antiphospholipid syndrome and infections in a child with trisomy 21. Autoimmun Rev 2008;8:121-3. [PMID: 18573354 DOI: 10.1016/j.autrev.2008.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
5 Shaw RJ, Bradbury C, Abrams ST, Wang G, Toh CH. COVID-19 and immunothrombosis: emerging understanding and clinical management. Br J Haematol 2021;194:518-29. [PMID: 34114204 DOI: 10.1111/bjh.17664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Canpolat N, Topal N, Civilibal M, Caliskan S, Sever L, Kasapcopur O, Baserer T, Arisoy N. A case of catastrophic antiphospholipid syndrome in an adolescent girl with parvovirus B19 infection. Clin Pediatr (Phila) 2008;47:593-7. [PMID: 18566354 DOI: 10.1177/0009922808315216] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
7 Xiao M, Zhang Y, Zhang S, Qin X, Xia P, Cao W, Jiang W, Chen H, Ding X, Zhao H, Zhang H, Wang C, Zhao J, Sun X, Tian R, Wu W, Wu D, Ma J, Chen Y, Zhang D, Xie J, Yan X, Zhou X, Liu Z, Wang J, Du B, Qin Y, Gao P, Lu M, Hou X, Wu X, Zhu H, Xu Y, Zhang W, Li T, Zhang F, Zhao Y, Li Y, Zhang S. Antiphospholipid Antibodies in Critically Ill Patients With COVID-19. Arthritis Rheumatol 2020;72:1998-2004. [PMID: 32602200 DOI: 10.1002/art.41425] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 23.5] [Reference Citation Analysis]
8 Malbora B, Bilaloglu E. Lupus Anticoagulant Positivity in Pediatric Patients With Prolonged Activated Partial Thromboplastin Time: A Single-Center Experience and Review of Literature. Pediatric Hematology and Oncology 2015;32:495-504. [DOI: 10.3109/08880018.2015.1065302] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Awwad ST, Heilman M, Hogan RN, Parmar DN, Petroll WM, Mcculley JP, Cavanagh HD. Severe Reactive Ischemic Posterior Segment Inflammation in Acanthamoeba Keratitis. Ophthalmology 2007;114:313-20. [DOI: 10.1016/j.ophtha.2006.07.038] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
10 Devreese KM. Antiphospholipid antibody testing and standardization. Int J Lab Hematol 2014;36:352-63. [PMID: 24750682 DOI: 10.1111/ijlh.12234] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 7.3] [Reference Citation Analysis]
11 Mazzoccoli C, Comitangelo D, D'Introno A, Mastropierro V, Sabbà C, Perrone A. Antiphospholipid syndrome: a case report with an unusual wide spectrum of clinical manifestations. Auto Immun Highlights 2019;10:9. [PMID: 32257065 DOI: 10.1186/s13317-019-0119-3] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Alvarez Suero J, Moyano Franco MJ, Serrano Carrillo JL, Venero Gómez J. [Antiphospholipid antibodies induced by Chlamydia pneumoniae infections]. Med Clin (Barc) 2005;124:519. [PMID: 15847779 DOI: 10.1157/13073572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Elbagir S, Elshafie AI, Elagib EM, Mohammed NA, Aledrissy MI, Manivel VA, Pertsinidou E, Nur MA, Gunnarsson I, Svenungsson E, Rönnelid J. High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients. Lupus 2020;29:1412-22. [PMID: 32741301 DOI: 10.1177/0961203320945387] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Chow EY, Chiu WK. Severe acute respiratory syndrome and lupus anticoagulants in children. Br J Haematol 2003;123:367-8. [PMID: 14531923 DOI: 10.1046/j.1365-2141.2003.04608.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
15 Shi H, Zuo Y, Navaz S, Harbaugh A, Hoy C, Gandhi AA, Sule G, Yalavarthi S, Gockman K, Madison JA, Wang J, Zuo M, Shi Y, Maile MD, Knight JS, Kanthi Y. Endothelial cell-activating antibodies in COVID-19. medRxiv 2021:2021. [PMID: 33501469 DOI: 10.1101/2021.01.18.21250041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
16 Wong R, Favaloro E, Adelstein S, Baumgart K, Bird R, Brighton T, Empson M, Gillis D, Hendle M, Laurent R, Mallon D, Pollock W, Smith S, Steele R, Wilson R. Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting. Pathology 2008;40:58-63. [DOI: 10.1080/00313020701717720] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
17 Gil-Etayo FJ, Garcinuño S, Lalueza A, Díaz-Simón R, García-Reyne A, Pleguezuelo DE, Cabrera-Marante O, Rodriguez-Frias EA, Perez-Rivilla A, Serrano M, Serrano A. Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor. Biomedicines 2021;9:899. [PMID: 34440103 DOI: 10.3390/biomedicines9080899] [Reference Citation Analysis]
18 Tkachenko O, Lapin S, Mazing A, Emanuel V, Belolipetskaia E, Beliaeva I, Myachikova V, Maslyanskiy A, Gilburd B, Schierack P, Roggenbuck D. Profiling of non-criteria antiphospholipid antibodies in patients with SLE: differentiation of thrombotic SLE patients and risk of recurrence of thrombosis. Lupus 2020;29:490-8. [DOI: 10.1177/0961203320909952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Martirosyan A, Aminov R, Manukyan G. Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation. Front Immunol 2019;10:1609. [PMID: 31354742 DOI: 10.3389/fimmu.2019.01609] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
20 Zuo Y, Estes SK, Ali RA, Gandhi AA, Yalavarthi S, Shi H, Sule G, Gockman K, Madison JA, Zuo M, Yadav V, Wang J, Woodard W, Lezak SP, Lugogo NL, Smith SA, Morrissey JH, Kanthi Y, Knight JS. Prothrombotic antiphospholipid antibodies in COVID-19. medRxiv 2020:2020. [PMID: 32587992 DOI: 10.1101/2020.06.15.20131607] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 12.5] [Reference Citation Analysis]
21 Flateau C, Asfalou I, Deman AL, Ficko C, Andriamanantena D, Fontan E, Viant E, Bonnevie L, Rapp C. Aortic thrombus and multiple embolisms during a Mycoplasma pneumoniae infection. Infection 2013;41:867-73. [PMID: 23696110 DOI: 10.1007/s15010-013-0475-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
22 Roszkiewicz J, Smolewska E. Kaleidoscope of autoimmune diseases in HIV infection. Rheumatol Int 2016;36:1481-91. [DOI: 10.1007/s00296-016-3555-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
23 Pourafkari L, Mirza-Aghzadeh-Attari M, Zarrintan A, Mousavi-Aghdas SA. Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study. Iran J Med Sci 2021;46:1-14. [PMID: 33487787 DOI: 10.30476/ijms.2020.87233.1730] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Lerma LA, Chaudhary A, Bryan A, Morishima C, Wener MH, Fink SL. Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19). J Transl Autoimmun 2020;3:100073. [PMID: 33263103 DOI: 10.1016/j.jtauto.2020.100073] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
25 Ferrari E, Sartre B, Squara F, Contenti J, Occelli C, Lemoel F, Levraut J, Doyen D, Dellamonica J, Mondain V, Chirio D, Risso K, Cua E, Orban JC, Ichai C, Labbaoui M, Mossaz B, Moceri P, Appert-Flory A, Fischer F, Toulon P. High Prevalence of Acquired Thrombophilia Without Prognosis Value in Patients With Coronavirus Disease 2019. J Am Heart Assoc 2020;9:e017773. [PMID: 32972320 DOI: 10.1161/JAHA.120.017773] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
26 Vidal M, Corbin V, Chanet V, Ruivard M, Gourdon F, Laurichesse H, Beytout J, Lesens O. Infections associées à des évènements thrombotiques sévères avec présence d'anticorps antiphospholipides. Médecine et Maladies Infectieuses 2005;35:552-5. [DOI: 10.1016/j.medmal.2005.08.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
27 Brusch A. The Significance of Anti-Beta-2-Glycoprotein I Antibodies in Antiphospholipid Syndrome. Antibodies (Basel) 2016;5:E16. [PMID: 31557997 DOI: 10.3390/antib5020016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
28 Scherer EM, Zwick MB, Teyton L, Burton DR. Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity. AIDS 2007;21:2131-9. [PMID: 18090039 DOI: 10.1097/QAD.0b013e3282a4a632] [Cited by in Crossref: 59] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
29 Kravitz MS, Shoenfeld Y. Thrombocytopenic conditions-autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT, and APS. Am J Hematol 2005;80:232-42. [PMID: 16247748 DOI: 10.1002/ajh.20408] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
30 Peker E, Kavakli K, Balkan C, Karapinar D, Aydemir B. Incidence and Clinical Importance of Lupus Anticoagulant in Children With Recurrent Upper Respiratory Tract Infection. Clin Appl Thromb Hemost 2011;17:220-4. [DOI: 10.1177/1076029609351292] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
31 Levine AB, Lockshin MD. Antiphospholipid Syndrome. In: Sammaritano LR, Bermas BL, editors. Contraception and Pregnancy in Patients with Rheumatic Disease. New York: Springer; 2014. pp. 109-37. [DOI: 10.1007/978-1-4939-0673-4_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
32 [DOI: 10.1101/198796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Taha M, Samavati L. Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review. RMD Open 2021;7:e001580. [PMID: 33958439 DOI: 10.1136/rmdopen-2021-001580] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
34 Soto-vega E, Ruiz-argüelles A, Mendoza-pinto C, Hernández-molina JR, Varela-cabrera JA, Muñoz-pérez MJ, Labastida-mercado N, García-carrasco M, Rivadeneyra-espinoza L, Arroyo C. Antiphospholipid antibodies in Mexican HIV-positive patients. Inmunología 2013;32:12-6. [DOI: 10.1016/j.inmuno.2012.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Lou M, Yuan D, Liao S, Tong L, Li J. Potential mechanisms of cerebrovascular diseases in COVID-19 patients. J Neurovirol 2021;27:35-51. [PMID: 33534131 DOI: 10.1007/s13365-021-00948-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
36 Connell NT, Battinelli EM, Connors JM. Coagulopathy of COVID-19 and antiphospholipid antibodies. J Thromb Haemost 2020. [PMID: 32379918 DOI: 10.1111/jth.14893] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 21.5] [Reference Citation Analysis]
37 Barnabe C, Fahlman N. Overlapping clinical features of lupus and leptospirosis. Clin Rheumatol 2008;27 Suppl 1:S23-5. [PMID: 18193381 DOI: 10.1007/s10067-007-0823-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
38 Azarsiz E, Eman G, Akarcan SE, Severcan EU, Karaca N, Aksu G, Kutukculer N. Antı-β2 Glycoprotein I Antibodies in Children with Rheumatologic Disorders. Indian J Clin Biochem 2019;34:95-100. [PMID: 30728679 DOI: 10.1007/s12291-017-0711-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
39 Cervera R, Espinosa G, Cordero A, Oltra MR, Unzurrunzaga A, Rossiñol T, Plaza J, Bucciarelli S, Ramos-Casals M, Ingelmo M, Asherson RA, Font J; Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group. Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS. Semin Arthritis Rheum 2007;36:287-96. [PMID: 17207521 DOI: 10.1016/j.semarthrit.2006.09.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
40 Alcock R, Elsik M, Yiannikas C, Yiannikas J. Antiphospholipid syndrome and rheumatic fever: a case spanning three decades of changing concepts and common immunological mechanisms. Lupus 2011;20:1316-20. [PMID: 21669913 DOI: 10.1177/0961203311403023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
41 Pisano TJ, Hakkinen I, Rybinnik I. Large Vessel Occlusion Secondary to COVID-19 Hypercoagulability in a Young Patient: A Case Report and Literature Review. J Stroke Cerebrovasc Dis 2020;29:105307. [PMID: 32992201 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105307] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
42 Liu T, Dai J, Yang Z, Yu X, Xu Y, Shi X, Wei D, Tang Z, Xu G, Xu W, Liu Y, Shi C, Ni Q, Yang C, Zhang X, Wang X, Chen E, Qu J. Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort. Sci Bull (Beijing) 2021. [PMID: 34336365 DOI: 10.1016/j.scib.2021.07.033] [Reference Citation Analysis]
43 Iordache L, Bengoufa D, Taulera O, Rami A, Lascoux-Combe C, Day N, Parrinello M, Sellier PO, Molina JM, Mahr A. Nonorgan-specific autoantibodies in HIV-infected patients in the HAART era. Medicine (Baltimore). 2017;96:e6230. [PMID: 28272216 DOI: 10.1097/md.0000000000006230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
44 Hsu YW, Juan CJ, Lee JT, Lin YK, Lai CH, Yang FC. Anti-N-Methyl-D-Aspartate-Receptor Encephalitis Complicated With Antiphospholipid Syndrome and Cerebral Venous Thrombosis. J Clin Rheumatol 2017;23:294-5. [PMID: 28742728 DOI: 10.1097/RHU.0000000000000577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
45 Lally L, Sammaritano LR. Vasculitis in Antiphospholipid Syndrome. Rheumatic Disease Clinics of North America 2015;41:109-23. [DOI: 10.1016/j.rdc.2014.09.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
46 Chaturvedi S, Braunstein EM, Brodsky RA. Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications. J Thromb Haemost 2021;19:607-16. [PMID: 32881236 DOI: 10.1111/jth.15082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Harel M, Aron-Maor A, Sherer Y, Blank M, Shoenfeld Y. The infectious etiology of the antiphos-pholipid syndrome: links between infection and autoimmunity. Immunobiology. 2005;210:743-747. [PMID: 16325492 DOI: 10.1016/j.imbio.2005.10.004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
48 Levy RA, de Meis E, Pierangeli S. An adapted ELISA method for differentiating pathogenic from nonpathogenic aPL by a beta 2 glycoprotein I dependency anticardiolipin assay. Thrombosis Research 2004;114:573-7. [DOI: 10.1016/j.thromres.2004.06.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
49 Szabó G, Antal-Szalmás P, Kerényi A, Pénzes K, Bécsi B, Kappelmayer J. Laboratory Approaches to Test the Function of Antiphospholipid Antibodies. Semin Thromb Hemost 2021. [PMID: 34261151 DOI: 10.1055/s-0041-1730357] [Reference Citation Analysis]
50 Matyas GR, Alving CR. Antigen-specific enhancement of natural human IgG antibodies to phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol-4-phosphate, cholesterol, and lipid A by a liposomal vaccine containing lipid A. Vaccine 2011;29:5137-44. [PMID: 21624414 DOI: 10.1016/j.vaccine.2011.05.042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
51 Tzang BS, Tsay GJ, Lee YJ, Li C, Sun YS, Hsu TC. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production. Clin Chim Acta 2007;378:59-65. [PMID: 17169353 DOI: 10.1016/j.cca.2006.10.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
52 Ramos-casals M, Fornsb X, Sanchez-tapiasb J, Rodésb J. Chapter 16 Extrahepatic Manifestations in Patients with Chronic Hepatitis C Virus Infection. Digestive Involvement in Systemic Autoimmune Diseases. Elsevier; 2008. pp. 209-304. [DOI: 10.1016/s1571-5078(07)00016-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Graffin B, Goutorbe P, Poyet R, Raymond A, Paris J, Carli P. Défaillance multiviscérale au cours d'un choc septique d'origine urinaire à Escherichia coli: syndrome catastrophique des anticorps antiphospholipides? La Revue de Médecine Interne 2007;28:52-5. [DOI: 10.1016/j.revmed.2006.10.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
54 [DOI: 10.1101/2021.01.21.21249176] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
55 Valesini G, Alessandri C. New Facet of Antiphospholipid Antibodies. Annals of the New York Academy of Sciences 2005;1051:487-97. [DOI: 10.1196/annals.1361.089] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
56 Guillet H, Gallet R, Pham V, D'Humières T, Huguet R, Lim P, Michel M, Khellaf M. Clinical spectrum of ischaemic arterial diseases associated with COVID-19: a series of four illustrative cases. Eur Heart J Case Rep 2021;5:ytaa488. [PMID: 33542975 DOI: 10.1093/ehjcr/ytaa488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Dieltjens T, Heyndrickx L, Willems B, Gray E, Van Nieuwenhove L, Grupping K, Vanham G, Janssens W. Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies. Retrovirology 2009;6:113. [PMID: 20003438 DOI: 10.1186/1742-4690-6-113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
58 Arora G, Hart T, Fikrig E. Use of host lipids by the Lyme disease spirochete may lead to biomarkers. J Clin Invest 2022;132:e158254. [PMID: 35289311 DOI: 10.1172/JCI158254] [Reference Citation Analysis]
59 Chae HJ, Kim JW, Lee YL, Park JH, Lee SY. Mononeuropathy multiplex associated with systemic vasculitis: A case report. World J Clin Cases 2021; 9(7): 1741-1747 [PMID: 33728320 DOI: 10.12998/wjcc.v9.i7.1741] [Reference Citation Analysis]
60 Germano N, Mendonça P, Murinello A. [Pulmonary embolism associated to HIV infection]. Rev Port Pneumol 2005;11:407-12. [PMID: 16240057 DOI: 10.1016/s0873-2159(15)30517-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Sidelmann JJ, Sjøland JA, Gram J, Bertelsen V, Mourits-Andersen T, Münster H, Münster AM, Jespersen J. Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis. Scand J Clin Lab Invest 2007;67:270-9. [PMID: 17454841 DOI: 10.1080/00365510601038992] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
62 Casares D, Escribá PV, Rosselló CA. Membrane Lipid Composition: Effect on Membrane and Organelle Structure, Function and Compartmentalization and Therapeutic Avenues. Int J Mol Sci 2019;20:E2167. [PMID: 31052427 DOI: 10.3390/ijms20092167] [Cited by in Crossref: 154] [Cited by in F6Publishing: 134] [Article Influence: 51.3] [Reference Citation Analysis]
63 Patel N, Patel N, Espinoza LR. HIV infection and rheumatic diseases: the changing spectrum of clinical enigma. Rheum Dis Clin North Am 2009;35:139-61. [PMID: 19481002 DOI: 10.1016/j.rdc.2009.03.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
64 de Larrañaga GF, Remondino GI, Forastiero RR, Cunto ER, Narbaitz M, Olenchuk AB, Zala NS, San Juan JA. Catastrophic antiphospholipid syndrome and Kikuchi-Fujimoto disease: the first case reported. Lupus 2005;14:967-9. [PMID: 16425578 DOI: 10.1191/0961203305lu2232cr] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
65 Lai M, d'Onofrio G, Visconti E, Tamburrini E, Cauda R, Leone G. Aetiological factors related to a positive direct antiglobulin test result in human immunodeficiency virus-infected patients. Vox Sang 2006;90:325-30. [DOI: 10.1111/j.1423-0410.2006.00755.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
66 Erkan D, Lockshin MD. What is antiphospholipid syndrome? Curr Rheumatol Rep 2004;6:451-7. [DOI: 10.1007/s11926-004-0024-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
67 Noakes D, Evans K, Pathansali R. The return of a former foe: syphilis with antiphospholipid syndrome as a cause of acute stroke. JRSM Open 2017;8:2054270417725498. [PMID: 28904807 DOI: 10.1177/2054270417725498] [Reference Citation Analysis]
68 Adhikari A, Chisti MM, Bastola S, Kc O. Rare case of catastrophic antiphospholipid syndrome with spontaneous intracranial haemorrhage. BMJ Case Rep 2019;12:e227171. [PMID: 30898956 DOI: 10.1136/bcr-2018-227171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
69 Nakayama T, Akahoshi M, Irino K, Kimoto Y, Arinobu Y, Niiro H, Tsukamoto H, Horiuchi T, Akashi K. Transient antiphospholipid syndrome associated with primary cytomegalovirus infection: a case report and literature review. Case Rep Rheumatol 2014;2014:271548. [PMID: 25548710 DOI: 10.1155/2014/271548] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
70 Deshpande P, Lucas M, Brunt S, Lucas A, Hollingsworth P, Bundell C. Low level autoantibodies can be frequently detected in the general Australian population. Pathology 2016;48:483-90. [PMID: 27339947 DOI: 10.1016/j.pathol.2016.03.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
71 Vlachoyiannopoulos PG, Samarkos M, Sikara M, Tsiligros P. Antiphospholipid antibodies: laboratory and pathogenetic aspects. Crit Rev Clin Lab Sci. 2007;44:271-338. [PMID: 17453920 DOI: 10.1080/10408360601079549] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
72 Landau N, Shoenfeld Y, Negru L, Segal G. Exploring the pathways of inflammation and coagulopathy in COVID-19: A narrative tour into a viral rabbit hole. Int Rev Immunol 2021;:1-9. [PMID: 34678120 DOI: 10.1080/08830185.2021.1993211] [Reference Citation Analysis]
73 Kashef S, Karimi M, Amirghofran Z, Ayatollahi M, Pasalar M, Ghaedian MM, Kashef MA. Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients. Int J Lab Hematol 2008;30:11-6. [PMID: 18190462 DOI: 10.1111/j.1751-553X.2007.00916.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
74 Irimia A, Sarkar A, Stanfield RL, Wilson IA. Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10. Immunity 2016;44:21-31. [PMID: 26777395 DOI: 10.1016/j.immuni.2015.12.001] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 10.3] [Reference Citation Analysis]
75 [DOI: 10.1101/057356] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
76 Badwe RA, Dikshit R, Chaturvedi P, Gupta S. Geographical & seasonal variation in COVID-19 related mortality. Indian J Med Res 2020;152:6-8. [PMID: 32773421 DOI: 10.4103/ijmr.IJMR_2043_20] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
77 Pascolini S, Vannini A, Deleonardi G, Ciordinik M, Sensoli A, Carletti I, Veronesi L, Ricci C, Pronesti A, Mazzanti L, Grondona A, Silvestri T, Zanuso S, Mazzolini M, Lalanne C, Quarneti C, Fusconi M, Giostra F, Granito A, Muratori L, Lenzi M, Muratori P. COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful? Clin Transl Sci 2021;14:502-8. [PMID: 32989903 DOI: 10.1111/cts.12908] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 27.0] [Reference Citation Analysis]
78 Merrill JT. Do antiphospholipid antibodies develop for a purpose? Curr Rheumatol Rep 2006;8:109-13. [DOI: 10.1007/s11926-006-0050-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
79 Ahmed S, Zimba O, Gasparyan AY. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Clin Rheumatol. 2020;39:2529-2543. [PMID: 32654082 DOI: 10.1007/s10067-020-05275-1] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 31.0] [Reference Citation Analysis]
80 Biradar S, Holyachi R, Kadeli DK. Purpura Fulminans Secondary to Rickettsial Infection: A Case Report. J Clin Diagn Res 2015;9:OD01-2. [PMID: 26673422 DOI: 10.7860/JCDR/2015/12719.6701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
81 Pineton de Chambrun M, Frere C, Miyara M, Amoura Z, Martin-Toutain I, Mathian A, Hekimian G, Combes A. Response to Letter: 'Reply to "High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?"'. J Intern Med 2021;289:427-9. [PMID: 32772406 DOI: 10.1111/joim.13166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
82 Mehrani T, Petri M. Chapter 2 Epidemiology of the Antiphospholipid Syndrome. Antiphospholipid Syndrome in Systemic Autoimmune Diseases. Elsevier; 2009. pp. 13-34. [DOI: 10.1016/s1571-5078(08)00402-9] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
83 Oztürk MA, Haznedaroğlu IC, Turgut M, Göker H. Current debates in antiphospholipid syndrome: the acquired antibody-mediated thrombophilia. Clin Appl Thromb Hemost 2004;10:89-126. [PMID: 15094931 DOI: 10.1177/107602960401000201] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
84 Hossri S, Shadi M, Hamarsha Z, Schneider R, El-Sayegh D. Clinically significant anticardiolipin antibodies associated with COVID-19. J Crit Care 2020;59:32-4. [PMID: 32512349 DOI: 10.1016/j.jcrc.2020.05.017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
85 Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 2006;65:2-6. [PMID: 16344491 DOI: 10.1136/ard.2005.045443] [Cited by in Crossref: 132] [Cited by in F6Publishing: 103] [Article Influence: 8.3] [Reference Citation Analysis]
86 Selton-Suty C, Maigrat CH, Devignes J, Goehringer F, Erpelding ML, Alla F, Thivilier C, Huttin O, Venner C, Juilliere Y, Doco-Lecompte T, Lecompte T; Endocarditis Team of the University Hospital of Nancy, France. Possible relationship between antiphospholipid antibodies and embolic events in infective endocarditis. Heart 2018;104:509-16. [PMID: 29305562 DOI: 10.1136/heartjnl-2017-312359] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
87 Clark CA, Laskin CA, Spitzer KA. Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence. Human Reproduction Update 2012;18:474-84. [DOI: 10.1093/humupd/dms020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
88 Amin NM. Antiphospholipid syndromes in infectious diseases. Hematol Oncol Clin North Am 2008;22:131-43, vii-viii. [PMID: 18207071 DOI: 10.1016/j.hoc.2007.10.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
89 Bakshi M, Khemani C, Vishwanathan V, Anand RK, Khubchandani RP. Mycoplasma pneumonia with antiphospholipid antibodies and a cardiac thrombus. Lupus 2006;15:105-6. [PMID: 16539282 DOI: 10.1191/0961203306lu2258cr] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
90 Jo JH, Son DW, Jeon I. Significance of Lupus Anticoagulant in Children with Prolonged Prothrombin Time/activated Partial Thromboplastin Time. Clin Pediatr Hematol Oncol 2016;23:34-41. [DOI: 10.15264/cpho.2016.23.1.34] [Reference Citation Analysis]
91 Shih FF, Racz J, Allen PM. Differential MHC class II presentation of a pathogenic autoantigen during health and disease. J Immunol 2006;176:3438-48. [PMID: 16517712 DOI: 10.4049/jimmunol.176.6.3438] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
92 Hautecloque G, Kempf C, Stan C, Arentz-Dugay MH, Vuillemet F, Ahle G, Sellal F, Martinot M. Multifocal and Microvascular Involvement in Ischemic Stroke During COVID-19: A Cohort Study With Comparison With Non-COVID-19 Stroke. Front Neurol 2021;12:732194. [PMID: 34759880 DOI: 10.3389/fneur.2021.732194] [Reference Citation Analysis]
93 Toyoshima M, Maegaki Y, Yotsumata K, Takei S, Kawano Y. Antiphospholipid syndrome associated with human herpesvirus-6 infection. Pediatr Neurol 2007;37:449-51. [PMID: 18021931 DOI: 10.1016/j.pediatrneurol.2007.08.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
94 Hodak E, David M. Primary Anetoderma and Antiphospholipid Antibodies—Review of the Literature. Clinic Rev Allerg Immunol 2007;32:162-6. [DOI: 10.1007/s12016-007-0011-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
95 Rodríguez Y, Rojas M, Gershwin ME, Anaya J. Tick-borne diseases and autoimmunity: A comprehensive review. Journal of Autoimmunity 2018;88:21-42. [DOI: 10.1016/j.jaut.2017.11.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
96 Ruff WE, Vieira SM, Kriegel MA. The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome. Curr Rheumatol Rep. 2015;17:472. [PMID: 25475595 DOI: 10.1007/s11926-014-0472-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
97 Yan SB, Brandt JT, Correll NL, Um SL, Bourdage JS. Evaluation of anti-activated protein C antibody development in patients with severe sepsis from four clinical studies with drotrecogin alfa (activated). Journal of Thrombosis and Haemostasis 2009;7:1787-94. [DOI: 10.1111/j.1538-7836.2009.03601.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
98 Baker WF Jr, Bick RL. The clinical spectrum of antiphospholipid syndrome. Hematol Oncol Clin North Am 2008;22:33-52, v-vi. [PMID: 18207064 DOI: 10.1016/j.hoc.2007.10.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
99 García-Carrasco M, Galarza-Maldonado C, Mendoza-Pinto C, Escarcega RO, Cervera R. Infections and the antiphospholipid syndrome. Clin Rev Allergy Immunol. 2009;36:104-108. [PMID: 19089659 DOI: 10.1007/s12016-008-8103-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
100 Ostrowski RA, Robinson JA. Antiphospholipid antibody syndrome and autoimmune diseases. Hematol Oncol Clin North Am 2008;22:53-65, vi. [PMID: 18207065 DOI: 10.1016/j.hoc.2007.10.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
101 Bonaci-Nikolic B, Andrejevic S, Pavlovic M, Dimcic Z, Ivanovic B, Nikolic M. Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge. Clin Rheumatol. 2010;29:893-904. [PMID: 20306213 DOI: 10.1007/s10067-010-1424-4] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
102 Ben-Chetrit E, Wiener-Well Y, Fadeela A, Wolf DG. Antiphospholipid antibodies during infectious mononucleosis and their long term clinical significance. J Clin Virol 2013;56:312-5. [PMID: 23290387 DOI: 10.1016/j.jcv.2012.12.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
103 Abdel-Wahab N, Lopez-Olivo MA, Pinto-Patarroyo GP, Suarez-Almazor ME. Systematic review of case reports of antiphospholipid syndrome following infection. Lupus 2016;25:1520-31. [PMID: 27060064 DOI: 10.1177/0961203316640912] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 8.3] [Reference Citation Analysis]
104 Shah R, Brodsky SV, Hebert L, Rovin BH, Nadasdy T, Satoskar AA. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies. Lupus 2018;27:2236-44. [PMID: 30403144 DOI: 10.1177/0961203318809177] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
105 Ojo AS, Balogun SA, Idowu AO. Acute Ischemic Stroke in COVID-19: Putative Mechanisms, Clinical Characteristics, and Management. Neurol Res Int 2020;2020:7397480. [PMID: 33224529 DOI: 10.1155/2020/7397480] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
106 Kenny LC, Kell DB. Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father. Front Med (Lausanne) 2017;4:239. [PMID: 29354635 DOI: 10.3389/fmed.2017.00239] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
107 Ramos‐casals M, Cervera R, Lagrutta M, Medina F, García‐carrasco M, de la Red G, Bové A, Ingelmo M, Font J; the Hispanoamerican Study Group of Autoimmune Manifestations of Chronic Viral Disease (HISPAMEC). Clinical Features Related to Antiphospholipid Syndrome in Patients with Chronic Viral Infections (Hepatitis C Virus/HIV Infection): Description of 82 Cases. CLIN INFECT DIS 2004;38:1009-16. [DOI: 10.1086/382537] [Cited by in Crossref: 57] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
108 Lee A, Nahm CH, Lee JS, Lee MK, Lee KR. Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19. J Clin Lab Anal 2021;35:e24004. [PMID: 34608677 DOI: 10.1002/jcla.24004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
109 Pichenot M, Morell-dubois S, Flateau C, Deconinck L, Hatron P, Lambert M. Acute cytomegalovirus infection as a transient risk factor for thrombosis: Report of three cases and focus on specific coagulation pathways. Thrombosis Research 2013;132:145-7. [DOI: 10.1016/j.thromres.2013.04.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
110 Blank M, Eisenstein M, Asherson R, Cervera R, Shoenfeld Y. The Infectious Origin of the Antiphospholipid Syndrome. Infection and Autoimmunity. Elsevier; 2004. pp. 473-90. [DOI: 10.1016/b978-044451271-0.50037-5] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
111 Atienza MR, Respaldiza N, La Santa ED, Martín-garrido I, Medrano FJ, Varela JM, Calderón E. Antiphospholipid antibodies investigation in Pneumocystis jirovecii carriers. Scandinavian Journal of Infectious Diseases 2009;40:840-2. [DOI: 10.1080/00365540802179691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
112 Lee HJ, Kang YM, Lee E, Jeong BJ, Jo YJ, Seong JS, Woo YM, Jeong KH. A Case of Azygos Vein Thombosis Associated with Transient Antiphospholipid Syndrome in Urinary Tract Infection with Escherichia coli. J Rheum Dis 2016;23:118. [DOI: 10.4078/jrd.2016.23.2.118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 Yasuo K. A case of syphilis presenting with prolonged etiology-unrevealed fever, accompanying activated partial thromboplastin time prolongation. J Gen Fam Med 2018;19:211-4. [PMID: 30464868 DOI: 10.1002/jgf2.210] [Reference Citation Analysis]
114 Cimolai N. Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19. SN Compr Clin Med 2021;:1-16. [PMID: 34179695 DOI: 10.1007/s42399-021-00992-3] [Reference Citation Analysis]
115 Pati S, Muley SA, Grill MF, Coons S, Walker R. Post-streptococcal vasculopathy with evolution to Degos' disease. J Neurol Sci 2011;300:157-9. [PMID: 21035145 DOI: 10.1016/j.jns.2010.10.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
116 H Patel N, Padhiyar JK, Patel T, Patel A, Chhibber A, Raval R, Patel B. Antiphospholipid antibodies in a patient of Lucio phenomenon presenting with the gangrene of digits. Indian J Dermatol Venereol Leprol 2021;87:97-101. [PMID: 33063703 DOI: 10.4103/ijdvl.IJDVL_25_19] [Reference Citation Analysis]
117 Wang J, Mao J, Chen G, Huang Y, Zhou J, Gao C, Jin D, Zhang C, Wen J, Sun J. Evaluation on blood coagulation and C-reactive protein level among children with mycoplasma pneumoniae pneumonia by different chest imaging findings. Medicine (Baltimore) 2021;100:e23926. [PMID: 33545964 DOI: 10.1097/MD.0000000000023926] [Reference Citation Analysis]
118 Million M, Bardin N, Bessis S, Nouiakh N, Douliery C, Edouard S, Angelakis E, Bosseray A, Epaulard O, Branger S, Chaudier B, Blanc-Laserre K, Ferreira-Maldent N, Demonchy E, Roblot F, Reynes J, Djossou F, Protopopescu C, Carrieri P, Camoin-Jau L, Mege JL, Raoult D. Thrombosis and antiphospholipid antibody syndrome during acute Q fever: A cross-sectional study. Medicine (Baltimore) 2017;96:e7578. [PMID: 28723794 DOI: 10.1097/MD.0000000000007578] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
119 Hysa E, Gotelli E, Sammorì S, Cimmino MA, Paolino S, Pizzorni C, Sulli A, Smith V, Cutolo M. Immune system activation in polymyalgia rheumatica: Which balance between autoinflammation and autoimmunity? A systematic review. Autoimmun Rev 2021;:102995. [PMID: 34798314 DOI: 10.1016/j.autrev.2021.102995] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
120 Gast T, Kowal-Vern A, An G, Hanumadass ML. Purpura fulminans in an adult patient with Haemophilus influenzae sepsis: case report and review of the literature. J Burn Care Res 2006;27:102-7. [PMID: 16566545 DOI: 10.1097/01.bcr.0000194269.95027.51] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
121 Zhang Y, Cao W, Jiang W, Xiao M, Li Y, Tang N, Liu Z, Yan X, Zhao Y, Li T, Zhu T. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients. J Thromb Thrombolysis 2020;50:580-6. [PMID: 32648093 DOI: 10.1007/s11239-020-02182-9] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 27.0] [Reference Citation Analysis]
122 Mantovani Cardoso E, Hundal J, Feterman D, Magaldi J. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology. Clin Rheumatol 2020;39:2811-5. [PMID: 32720260 DOI: 10.1007/s10067-020-05310-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
123 Foret T, Dufrost V, Salomon Du Mont L, Costa P, Lefevre B, Lacolley P, Regnault V, Zuily S, Wahl D. Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders? Curr Rheumatol Rep 2021;23:65. [PMID: 34218350 DOI: 10.1007/s11926-021-01029-3] [Reference Citation Analysis]
124 Tong M, Tsai BW, Chamley LW. Antiphospholipid antibodies and extracellular vesicles in pregnancy. Am J Reprod Immunol 2021;85:e13312. [PMID: 32715546 DOI: 10.1111/aji.13312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
125 Simkins J, Corrales-Medina V, Symes S, Dickinson G. Pulmonary embolism in patients with acquired immunodeficiency syndrome presenting with clinical picture of Pneumocystis jiroveci pneumonia: report of two cases. Scand J Infect Dis 2007;39:634-6. [PMID: 17577835 DOI: 10.1080/00365540601148509] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
126 Groarke EM, Dulau-Florea AE, Kanthi Y. Thrombotic manifestations of VEXAS syndrome. Semin Hematol 2021;58:230-8. [PMID: 34802545 DOI: 10.1053/j.seminhematol.2021.10.006] [Reference Citation Analysis]
127 Yaseen Al-Khayat ZA, Waheda NE, Shaker NF. The prevalence of positive serum anticardiolipin antibodies and asymptomatic bacteriuria in women with recurrent abortions. Eurasian J Med 2013;45:39-42. [PMID: 25610246 DOI: 10.5152/eajm.2013.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
128 Zuo Y, Estes SK, Ali RA, Gandhi AA, Yalavarthi S, Shi H, Sule G, Gockman K, Madison JA, Zuo M, Yadav V, Wang J, Woodard W, Lezak SP, Lugogo NL, Smith SA, Morrissey JH, Kanthi Y, Knight JS. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med 2020;12:eabd3876. [PMID: 33139519 DOI: 10.1126/scitranslmed.abd3876] [Cited by in Crossref: 136] [Cited by in F6Publishing: 139] [Article Influence: 68.0] [Reference Citation Analysis]
129 Kell DB, Kenny LC. A Dormant Microbial Component in the Development of Preeclampsia. Front Med (Lausanne) 2016;3:60. [PMID: 27965958 DOI: 10.3389/fmed.2016.00060] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]